Trial Details
WITHDRAWNBasic Information
| Clinical ID | c2778 |
|---|---|
| Identifier | NCT02974322 |
| Trial Title | A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: GED-0301|DRUG: Placebo |
Participant Information
| Sponsor | Celgene |
|---|---|
| City | Litchfield Park |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2017-12-01 |
|---|---|
| Primary Completion Date | 2018-11-17 |
| Completion Date | 2018-12-24 |